蔚蓝生物：公司正积极布局宠物动保产品

Core Viewpoint - The company is actively expanding its pet health product line, with a long-term product planning scheme that includes chemical drugs, biological products, and pet health products [1] Group 1: Product Development - The company is focusing on self-branded production and sales of pet health products, without engaging in OEM business [1] - A comprehensive R&D and market operation team will be gradually established to support product promotion [1] Group 2: Market Strategy - The company plans to develop distribution channels primarily through offline veterinary hospitals [1] - The company will adhere to the disclosure obligations as per the Shanghai Stock Exchange regulations, ensuring timely announcements of relevant information [1]